Enewold L - Search Results

1

SERPINA1 and ELA2 polymorphisms are not associated with COPD or lung cancer.

Enewold L, Mechanic LE, Bowman ED, Platz EA, Alberg AJ. Enewold L, et al. Anticancer Res. 2012 Sep;32(9):3923-8. Anticancer Res. 2012. PMID: 22993338 Free PMC article.

2

Evaluation of the Completeness of Managed Care Data to Identify Cancer Diagnoses and Treatments for Patients in the SEER-Medicare Data.

Warren JL, Parsons HM, Mariotto AB, Boyd E, Enewold L. Warren JL, et al. Among authors: enewold l. Med Care. 2023 Dec 1;61(12):846-857. doi: 10.1097/MLR.0000000000001936. Epub 2023 Oct 4. Med Care. 2023. PMID: 37796197 Free PMC article.

3

Use of pembrolizumab among older adults with cancer in the United States, before and after FDA approval of its tumor-agnostic indication.

Hong YD, Enewold L, Halpern MT, Zeruto C, Mariotto AB. Hong YD, et al. Among authors: enewold l. Pharmacoepidemiol Drug Saf. 2024 Jan;33(1):e5745. doi: 10.1002/pds.5745. Epub 2023 Dec 29. Pharmacoepidemiol Drug Saf. 2024. PMID: 38156547 Free PMC article.

4

Incidence of papillary thyroid cancer: Comparison of the military and the general population by race and tumor stage/size.

Bytnar JA, Enewold L, Shriver CD, Zhu K. Bytnar JA, et al. Among authors: enewold l. Cancer Epidemiol. 2024 Apr;89:102539. doi: 10.1016/j.canep.2024.102539. Epub 2024 Feb 9. Cancer Epidemiol. 2024. PMID: 38340498

5

Accuracy of Cancer Registry Primary Payer Information and Implications for Policy Research.

Davidoff AJ, Enewold L, Williams CP, Bhattacharya M, Sanchez JI. Davidoff AJ, et al. Among authors: enewold l. Med Care. 2024 Mar 1;62(3):161-169. doi: 10.1097/MLR.0000000000001974. Epub 2024 Jan 8. Med Care. 2024. PMID: 38189658

6

Smoking increases carcinogenic polycyclic aromatic hydrocarbons in human lung tissue.

Goldman R, Enewold L, Pellizzari E, Beach JB, Bowman ED, Krishnan SS, Shields PG. Goldman R, et al. Among authors: enewold l. Cancer Res. 2001 Sep 1;61(17):6367-71. Cancer Res. 2001. PMID: 11522627

7

Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls.

Zheng YL, Loffredo CA, Yu Z, Jones RT, Krasna MJ, Alberg AJ, Yung R, Perlmutter D, Enewold L, Harris CC, Shields PG. Zheng YL, et al. Among authors: enewold l. Carcinogenesis. 2003 Feb;24(2):269-74. doi: 10.1093/carcin/24.2.269. Carcinogenesis. 2003. PMID: 12584177

8

Polymorphisms in XPD and TP53 and mutation in human lung cancer.

Mechanic LE, Marrogi AJ, Welsh JA, Bowman ED, Khan MA, Enewold L, Zheng YL, Chanock S, Shields PG, Harris CC. Mechanic LE, et al. Among authors: enewold l. Carcinogenesis. 2005 Mar;26(3):597-604. doi: 10.1093/carcin/bgh344. Epub 2004 Nov 25. Carcinogenesis. 2005. PMID: 15564288

9

TP53 mutation spectrum in lung cancer is not different in women and men.

Marrogi AJ, Mechanic LE, Welsh JA, Bowman ED, Khan MA, Enewold L, Shields PG, Harris CC. Marrogi AJ, et al. Among authors: enewold l. Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):1031-3. doi: 10.1158/1055-9965.EPI-04-0640. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15824188

10

Less efficient g2-m checkpoint is associated with an increased risk of lung cancer in African Americans.

Zheng YL, Loffredo CA, Alberg AJ, Yu Z, Jones RT, Perlmutter D, Enewold L, Krasna MJ, Yung R, Shields PG, Harris CC. Zheng YL, et al. Among authors: enewold l. Cancer Res. 2005 Oct 15;65(20):9566-73. doi: 10.1158/0008-5472.CAN-05-1003. Cancer Res. 2005. PMID: 16230422 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters